On Sat 25 Mar 2017 at 19:00, Christian Schulte <[email protected]> wrote:
> Am 03/25/17 um 07:17 schrieb Hervé BOUTEMY: > > MNG-6112 is harder to estimate side effects IMHO > > and since this has been available for a long time, I'm really not > satisfied > > that it has been integrated *after vote for 3.0.5-beta-1 started* (and in > > addition without any discussion) > > Issue has been mentioned by Michael Osipov somewhen during development > of 3.4.0 in MNG-4645. I just created a separate issue in JIRA for it. > There has been a discussion. There also has been an in depth search > starting from GIT back to the initial commit in subversion by me > documented in MNG-4645. > > <https://issues.apache.org/jira/browse/MNG-4645> > To risky. Out of scope for 3.5.0 > > > > I'd say punt to 3.5.1: benefit is not worth the risk for now (we lived > for > > years with that, we can stay with it for a couple of months to have wider > > tests) > > Last time I looked at it, Maven never updated release versions. Commit > is just making this explicit in the repository declaration. This > sentence "There are still 10 issues left in JIRA for 3.5.0," in the > vote email for beta-1 made me look at the list. I thought we already > agreed to these issues for 3.5.0 and just wanted to close the remaining > issues assigned to me. Not merged in time (and remember we agreed no merging without a seconded) > > Regards, > -- > Christian > > > --------------------------------------------------------------------- > To unsubscribe, e-mail: [email protected] > For additional commands, e-mail: [email protected] > > -- Sent from my phone
